[1]王 焕.替格瑞洛在氯吡格雷抵抗AMI患者PCI术后抗血小板治疗中的应用[J].医学信息,2019,32(24):153-154.[doi:10.3969/j.issn.1006-1959.2019.24.055]
　WANG Huan.Application of Ticagrelor in the Antiplatelet Therapy of Clopidogrel in Patients with AMI after PCI[J].Medical Information,2019,32(24):153-154.[doi:10.3969/j.issn.1006-1959.2019.24.055]
点击复制

替格瑞洛在氯吡格雷抵抗AMI患者PCI术后抗血小板治疗中的应用()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年24期
页码:
153-154
栏目:
药物与临床
出版日期:
2019-12-15

文章信息/Info

Title:
Application of Ticagrelor in the Antiplatelet Therapy of Clopidogrel in Patients with AMI after PCI
文章编号:
1006-1959（2019）24-0153-02
作者:
王 焕
（南开大学附属医院/天津市第四医院内科，天津 300222）
Author(s):
WANG Huan
(Nankai University Affiliated Hospital/Department of Internal Medicine,Tianjin Fourth Hospital,Tianjin 300222,China)
关键词:
替格瑞洛; 氯吡格雷; 急性心肌梗死; PCI术; 抗血小板
Keywords:
Ticagrelor; Clopidogrel; Acute myocardial infarction; PCI; Antiplatelet
分类号:
R542.2+2
DOI:
10.3969/j.issn.1006-1959.2019.24.055
文献标志码:
A
摘要:
目的 分析替格瑞洛在氯吡格雷抵抗急性心肌梗死（AMI）患者PCI术后抗血小板中的应用效果。方法 选取2018年2月~2019年2月在我院治疗的符合氯吡格雷抵抗标准的60例急性心肌梗死PCI术后患者为研究对象，采用随机数字表法分为对照组和观察组，各30例。对照组PCI术前加服氯吡格雷，术后高剂量维持，观察组术前加服替格瑞洛，术后常规剂量维持，比较两组不同时间段（术前、术后2、24、48 h）血小板聚集率、血清谷草转氨酶（AST）、血肌酐（Scr）及临床不良反应（心率衰竭、脑血管意外、心绞痛、脑缺血发作）发生情况。结果 两组术前血小板聚集率比较，差异无统计学意义（P＞0.05），观察组术后2、24、48 h血小板聚集率均低于对照组（P＜0.05）；术后两组AST、Scr均高于术前，且观察组高于对照组（P＜0.05）；术后观察组不良反应发生率（6.67%）低于对照组（26.67%），差异有统计学意义（P＜0.05）。结论 替格瑞洛治疗符合氯吡格雷抵抗标准的急性心肌梗死PCI术患者疗效确切，可降低血小板聚集率，减少肝肾损害，且不良反应少，具有较高的临床应用价值。
Abstract:
Objective To analyze the effect of clopidogrel on anti-platelet therapy after PCI in patients with acute myocardial infarction(AMI)with ticagrelor.Methods A total of 60 patients with acute myocardial infarction after PCI who were treated with clopidogrel resistance in our hospital from February 2018 to February 2019 were selected as the research subjects. They were divided into a control group and an observation group by random number table, each 30 example. The control group received clopidogrel before PCI and maintained a high dose after surgery. The observation group received ticagrelor before surgery and maintained a regular dose after surgery.The platelet aggregation rate, serum glutamic oxaloacetic transaminase (AST), serum creatinine (Scr) and clinical adverse reactions (heart rate failure, cerebral vascular accident, angina pectoris, ischemic attack) were compared between the two groups at different time points (before operation, 2, 24 and 48 h after operation).Results There was no significant difference in the platelet aggregation rate between the two groups before surgery (P>0.05). The platelet aggregation rate in the observation group was lower than that in the control group at 2, 24, and 48 h after surgery(P<0.05). The postoperative AST and Scr in the two groups were higher than before the operation, and the observation group was higher than the control group(P<0.05); the incidence of adverse reactions in the observation group was 6.67% lower than that in the control group 26.67%(P<0.05).Conclusion Ticagrelor is effective in treating patients with acute myocardial infarction and PCI following clopidogrel resistance. It can reduce platelet aggregation rate, reduce liver and kidney damage, and has fewer adverse reactions. It has high clinical application value.

参考文献/References:

[1]闫睿.替格瑞洛抗血小板治疗的疗效观察[J].中国循证心血管医学杂志,2014,5(2):138.[2]周燕,何泉.不同剂量氯吡格雷对急性心肌梗死患者急诊介入术后血小板聚集率和hs-CRP水平的影响[J].海南医学院学报,2014,20(7):923-925,929[3]刘刚.氯吡格雷联合低分子肝素钙治疗进展性缺血性脑卒中临床疗效观察[J].河北医学,2015,21(11):18501853.[4]郭瑞琦,吴迪,周艳秋,等.急性冠脉综合征患者氯吡格雷抵抗的相关影响因素分析[J].中国心血管病研究,2014,12(1):78-82.[5]高燕,卢学春,曹剑,等.老年冠心病患者氯吡格雷联用钙拮抗剂的疗效观察:一项基于倾向评分的回顾性队列研究[J].南方医科大学学报,2012,32(4):462-466.

相似文献/References:

[1]刘 华,康美尼,王兴华,等.替格瑞洛对oxLDL诱导的人脐静脉内皮细胞ICAM-1表达的影响[J].医学信息,2018,31(22):81.[doi:10.3969/j.issn.1006-1959.2018.22.022]
　LIU Hua,KANG Mei-ni,WANG Xing-hua,et al.Effect of Ticagrelor on the Expression of ICAM-1 in Human umbilical Vein Endothelial Cells Induced by oxLDL[J].Medical Information,2018,31(24):81.[doi:10.3969/j.issn.1006-1959.2018.22.022]
[2]梁道博,姚卜飞,夏双燕.氯吡格雷联合阿司匹林治疗急性冠脉综合征疗效与 安全性的Meta分析[J].医学信息,2019,32(11):76.[doi:10.3969/j.issn.1006-1959.2019.11.021]
　LIANG Dao-bo,YAO Bu-fei,XIA Shuang-yan.Meta-analysis of the Efficacy and Safety of Clopidogrel Combined with Aspirin in the Treatment of Acute Coronary Syndrome[J].Medical Information,2019,32(24):76.[doi:10.3969/j.issn.1006-1959.2019.11.021]
[3]张 毅.替格瑞洛对不稳定型心绞痛患者PCI术后缺血事件及炎症因子水平的影响[J].医学信息,2022,35(13):130.[doi:10.3969/j.issn.1006-1959.2022.13.030]
　ZHANG Yi.Effect of Ticagrelor on Ischemic Events and Inflammatory Factors in Patients with Unstable Angina Pectoris After PCI[J].Medical Information,2022,35(24):130.[doi:10.3969/j.issn.1006-1959.2022.13.030]
[4]吴浩瑜.院前急救中应用不同抗血小板药物组合对ST段抬高型急性心肌梗死患者近期心血管事件的影响[J].医学信息,2021,34(22):57.[doi:10.3969/j.issn.1006-1959.2021.22.016]
　WU Hao-yu.Effects of Different Antiplatelet Drug Combinations in Pre-hospital Emergency Treatment on Recent Cardiovascular Events in Patients with ST-segment Elevation Acute Myocardial Infarction[J].Medical Information,2021,34(24):57.[doi:10.3969/j.issn.1006-1959.2021.22.016]
[5]刘廷胜.氯吡格雷联合阿司匹林治疗急性心肌梗死的研究[J].医学信息,2020,33(06):59.[doi:10.3969/j.issn.1006-1959.2020.06.018]
　LIU Ting-sheng.A Study of Clopidogrel Combined with Aspirin in the Treatment of Acute Myocardial Infarction[J].Medical Information,2020,33(24):59.[doi:10.3969/j.issn.1006-1959.2020.06.018]
[6]程 林.替格瑞洛对冠心病患者PCI治疗术后冠脉微循环功能的影响[J].医学信息,2020,33(07):156.[doi:10.3969/j.issn.1006-1959.2020.07.051]
　CHENG Lin.Effect of Ticagrelor on Coronary Microcirculation Function in Patients with Coronary Heart Disease After PCI Treatment[J].Medical Information,2020,33(24):156.[doi:10.3969/j.issn.1006-1959.2020.07.051]
[7]程 林.低剂量替格瑞洛治疗稳定型冠心病患者的疗效及安全性评价[J].医学信息,2020,33(08):161.[doi:10.3969/j.issn.1006-1959.2020.08.053]
　CHENG Lin.Efficacy and Safety of Low-dose Ticagrelor in the Treatment of Stable Coronary Heart Disease[J].Medical Information,2020,33(24):161.[doi:10.3969/j.issn.1006-1959.2020.08.053]
[8]栾学冰.拜阿斯匹林、那曲肝素联合氯吡格雷治疗急性ST段抬高型心肌梗死疗效[J].医学信息,2020,33(09):136.[doi:10.3969/j.issn.1006-1959.2020.09.043]
　LUAN Xue-bing.The Efficacy of Bayaspirin,Naltreparin Combined with Clopidogrel in the Treatment of Acute ST-segment Elevation Myocardial Infarction[J].Medical Information,2020,33(24):136.[doi:10.3969/j.issn.1006-1959.2020.09.043]
[9]刘 楠.阿司匹林联合氯吡格雷双抗血小板治疗脑梗死的疗效观察及对血清hs-CRP及D-D水平的影响[J].医学信息,2022,35(19):82.[doi:10.3969/j.issn.1006-1959.2022.19.022]
　LIU Nan.The Effect of Aspirin Combined with Clopidogrel Dual Antiplatelet Therapy on Cerebral Infarction and its Effect on Serum hs-CRP and D-D Levels[J].Medical Information,2022,35(24):82.[doi:10.3969/j.issn.1006-1959.2022.19.022]
[10]赵东慧.阿替普酶静脉溶栓联合氯吡格雷对急性脑梗死患者脑血流动力学及CRP、Hcy、HDL-C水平的影响[J].医学信息,2022,35(20):74.[doi:10.3969/j.issn.1006-1959.2022.20.018]
　ZHAO Dong-hui.Effect of Alteplase Intravenous Thrombolysis Combined with Clopidogrel on Cerebral Hemodynamics and Levels of CRP, Hcy and HDL-C in Patients with Acute Cerebral Infarction[J].Medical Information,2022,35(24):74.[doi:10.3969/j.issn.1006-1959.2022.20.018]
[11]陈 娟,刘俊敏,曾媛梅.替格瑞洛与氯吡格雷对急性ST段抬高型心肌梗死患者临床疗效及心电图变化的影响[J].医学信息,2025,38(12):86.[doi:10.3969/j.issn.1006-1959.2025.12.017]
　CHEN Juan,LIU Junmin,ZENG Yuanmei.Effects of Ticagrelor and Clopidogrel on Clinical Efficacy and Electrocardiogram Changes in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Medical Information,2025,38(24):86.[doi:10.3969/j.issn.1006-1959.2025.12.017]

更新日期/Last Update: 2019-12-15